Control of immune responses induced by the transfer of allogeneic white blood cells during transfusion

Transfusion

Volumn 45, Issue SUPPL. 2, 2005, Pages

  Fast, Loren D ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PSORALEN; HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGENICITY; BLOOD DONOR; BLOOD TRANSFUSION; BONE MARROW HYPOPLASIA; CELL FUNCTION; GAMMA IRRADIATION; GENE LOCUS; GRAFT VERSUS HOST REACTION; HUMAN; LEUKOCYTE; MOUSE MUTANT; NONHUMAN; REVIEW; SYNTENY; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ANIMAL; APOPTOSIS; GAMMA RADIATION; IMMUNOLOGY; LEUKOCYTE TRANSFUSION; PHYSIOLOGY; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; GAMMA RAYS; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LEUKOCYTE TRANSFUSION; LEUKOCYTES; ULTRAVIOLET RAYS;

EID: 23844500061     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00530.x     Document Type: Review

References (60)

1. Vamvakas EC Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001 97 : 1180 95.
2. Lee JH Klein H. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes. Bailliere's Clin Hemat 2000 13 : 585 600.
3. Gould DS Auchincloss J. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999 20 : 77 82.
4. Shlomchik W. Antigen presentation in graft-versus-host disease. Exp Hematol 2003 31 : 1187 97.
5. Fast LD. Recipient CD8+ cells are responsible for the rapid elimination of allogeneic donor lymphoid cells. J Immunol 1996 157 : 4805 10.
6. Fast L. The effect of exposing murine splenocytes to UVB light, psoralen plus UVA light or gamma-irradiation on in vitro and in vivo immune responses. Transfusion 2003 43 : 576 83.
7. Kao KJ. Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects. Transfus Med Rev 2000 14 : 12 22.
8. Fast LD. Identification of a single non-H-2 gene regulating graft-versus-host disease response. J Immunol 1990 144 : 4177 82.
9. Gleichman E Pals ST Rolink AG, et al. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 1984 5 : 324 32.
10. Anderson KC. Transfusion-associated graft-versus-host disease. In: Ferrara JL Deeg HJ Burakoff SJ, editors. Graft-vs.-host disease. New York : Dekker; 1997. p. 587 606.
11. Kruskall MS Alper CA Adweh Z Yunis EJ. HLA-homozygous donors and transfusion-associated graft-versus-host disease. N Engl J Med 1990 322 : 1005.
12. Ohto H Yasuda H Noguchi M Abe R. Risk of transfusion-associated graft-versus-host disease as a result of direct donations from relatives. Transfusion 1992 2 : 691.
13. Fast LD Valeri CR Crowley JP. Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease. Blood 1995 86 : 3090 6.
14. Fast LD. In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease. J Immunol 1991 147 : 1731.
15. Fast LD. Generation and characterization of IL-2 activated veto cells. J Immunol 1992 149 : 1510.
16. Carrington M Norman P. The KIR gene cluster (electronic resource). Bethesda : National Center for Biotechnology Information; 2003.
17. Grass JA Wafa T Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. J Immunol 1999 93 : 3140 7.
18. Moroff G Luban NL. The irradiation of blood and blood components to prevent graft-versus-host disease: technical issues and guidelines. Transfus Med Rev 1997 11 : 15 26.
19. Pamphilon DH. The rationale and use of platelet concentrates irradiated with ultraviolet-B light. Transfus Med Rev 1999 13 : 325 33.
20. Pelszynski M Moroff G Luban N, et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host-disease. Blood 1994 83 : 1683 9.
21. Ohto H. Gamma radiation does not prevent transfusion-induced HLA alloimmunization. Transfusion 1997 37 : 878 9.
22. Fast L DiLeone G Purmal A, et al. Treatment of RBC units with INACTINE PEN110 inhibits graft-versus-host disease as effectively as gamma-irradiation. Transfusion 2002 42 : 27S.
23. Pamphilon DH Alnaqdy AA Wallington TB. Immunomodulation by ultraviolet light: clinical studies and biological effects. Immunol Today 1991 12 : 119 23.
24. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 9.
25. Grass JA Hei DJ Metchette K, et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998 91 : 2180 8.
26. Corash L. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet and red cell concentrates. In: Brown F Vyas G, editors. Advances in transfusion safety: developmental biology. Basel : Karger 1999. p. 115 23.
27. Truitt RL Johnson BD Hanke C, et al. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. J Immunol 1999 163 : 5145 56.
28. Fast L DiLeone G Edson C Purmal A. INACTINE PEN110 treatment functionally inactivates the PBMNC present in RBC units: comparison to the effects of exposure to gamma-irradiation. Transfusion 2002 42 : 1318 25.
29. Fast L Semple J DiLeone G, et al. Inhibition of xenogeneic graft-versus-host disease by INACTINE PEN110 treatment of donor human peripheral blood mononuclear cells. Transfusion 2004 44 : 282 5.
30. van Rijn R Simonetti E Hagenbeek A, et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/-γc-/- double mutant mice. Blood 2003 102 : 2522 31.
31. Xia CQ Kao KJ. Induction of immune tolerance across major histocompatibility complex barrier by transfusion of ultraviolet B-irradiated immature dendritic cells. Transfusion 2005 45 : 181 8.
32. Fast L. Genotypic regulation of alloantibody production in response to ultraviolet B irradiated allogeneic donor cells. Transfusion 2003 43 : 1295 302.
33. Albert M. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 2004 4 : 223 33.
34. Bartholomae W Rininsland F Eisenberg J, et al. T cell immunity induced by live, necrotic, and apoptotic tumor cells. J Immunol 2004 173 : 1012 22.
35. Sauter B Albert MI Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000 191 : 423 33.
36. Boreham D Dolling J Maves S, et al. Dose-rate effects for apoptosis and micronucleus formation in gamma-irradiated human lymphocytes. Radiat Res 2000 153 : 579 86.
37. Caricchio R Reap EA Cohen PL. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J Immunol 1998 161 : 241 51.
38. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999 112 : 3 12.
39. Strasser A Pellegrini M. T-lymphocyte death during shutdown of an immune response. Trends Immunol 2004 25 : 610 5.
40. Zheng L He M Long M, et al. Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J Immunol 2004 173 : 6319 26.
41. Grainger DJ Reckless McKilligin E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proliferation state in apolipoprotein E-deficient mice. J Immunol 2004 173 : 6366 75.
42. Nauta A Castellano G Xu W, et al. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol 2004 173 : 3044 50.
43. Quartier P Potter P Ehrenstein M, et al. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol 2004 35 : 252 60.
44. Hoffman P Kench J Vondracek A, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol 2005 174 : 1393 404.
45. Bondanza A Zimmerman V Rovere-Querini P, et al. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 2004 200 : 2257 1165.
46. Chang MK Binder C Miller Y, et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004 200 : 1359 70.
47. Propato A Cutrona G Francavilla V, et al. Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med 2001 7 : 807 13.
48. Chen W Frank M Jin W Wahl S. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001 14 : 715 25.
49. Dzik S Mincheff M Puppo F. Apoptosis, transforming growth factor-β, and the immunosuppressive effect of transfusion. Transfusion 2002 42 : 1221 3.
50. Voll RE Herrmann M Roth EA, et al. Immunosuppressive effects of apoptotic cells. Nature 1997 390 : 350 1.
51. Martin A Kulski J Witt C, et al. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 2002 23 : 81 8.
52. Parham P McQueen K. Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat Immunol Rev 2003 3 : 108 22.
53. Brown DJ Trowsdale Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004 64 : 215 25.
54. Shiroishi M Tsumoto K Amano K, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003 100 : 8856 61.
55. Liang S Baibakov B Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 2002 32 : 2418 26.
56. Takai T Ono M. Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol Rev 2001 181 : 215 22.
57. Kubagawa H Chen CC Ho LH, et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med 1999 189 : 309 17.
58. Ujike A Takeda K Nakamura A, et al. Impaired dendritic cell maturation and increased TH2 responses in PIR-B-/- mice. Nat Immunol 2002 3 : 542 8.
59. Nakamura A Kobayashi E Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nat Immunol 2004 5 : 623 9.
60. Smit Sibinga C. Immune effects of blood transfusion. Curr Opin Hematol 1999 6 : 442 5.